Phase 4CompletedINTERVENTIONAL
Study on Lixisenatide and Counterregulation to Hypoglycemia
ClinicalTrials.gov · NCT02020629 · Registry updated: 2015-12-15
- Condition / research focus
- Type 2 Diabetes
- Sponsor
- Lund University
- Countries with listed sites
- Sweden
- Registry dates and results
- Start: 2013-12. Completion: 2015-08 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Lixisenatide (drug) — also listed as: Lyxumia
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Clinical Research Department
Malmö, Sweden
Site recruitment: Not reported